Mitchell P.J., Redfern P.H.
Pharmacology Group, School of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, Avon BA2 7AY, UK.
Behav Pharmacol. 1992 Jun;3(3):239-247.
Male Wistar rats housed in triads under a 12h: 12h light-dark schedule exhibit intense levels of social behaviour, involving all group members equally, at the onset of every dark phase. Analysis of this social behaviour yields the group's hierarchical structure (based on the proportion of wins attained during social interaction) consisting of a dominant, subdominant and subordinate rat. Chronic treatment of the subdominant rats with the antidepressant drugs clomipramine, 10µmol/kg day, and mianserin, 0.33µmol/kg/day, via subcutaneously-implanted osmotic mini-pumps, increased the proportion of wins attained during encounters with their sham-operated cage partners by day 6 of treatment. This increase was maintained throughout the remaining period of treatment and was generally at the expense of the level of dominance of the dominant rat. It is argued that the ability of clomipramine and mianserin to increase the proportion of wins attained by subdominant rats parallels the previously-reported drug-induced release of social and agonistic behaviour which is thought to be indicative of antidepressant activity.
按照12小时光照与12小时黑暗的时间表饲养在三联笼中的雄性Wistar大鼠,在每个黑暗阶段开始时都会表现出强烈的社交行为,所有组成员参与程度均等。对这种社交行为的分析产生了该组的等级结构(基于社交互动中获胜的比例),包括一只占主导地位、次主导地位和从属地位的大鼠。通过皮下植入渗透微型泵,以每天10微摩尔/千克的剂量给次主导地位的大鼠长期注射抗抑郁药物氯米帕明,以及以每天0.33微摩尔/千克的剂量注射米安色林,到治疗第6天时,与假手术的笼伴相遇时获胜的比例增加。在治疗的剩余时间里,这种增加一直保持,并且通常是以占主导地位大鼠的主导水平为代价。有人认为,氯米帕明和米安色林增加次主导地位大鼠获胜比例的能力与先前报道的药物诱导的社交和争斗行为释放相平行,这种行为被认为是抗抑郁活性的指标。